CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pospelov, V. A.
Right arrow Articles by Julien, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pospelov, V. A.
Right arrow Articles by Julien, J. P.

Cell Growth & Differentiation, Vol 5, Issue 2 187-196, Copyright © 1994 by American Association of Cancer Research

ARTICLES

AP-1 and Krox-24 transcription factors activate the neurofilament light gene promoter in P19 embryonal carcinoma cells

VA Pospelov, TV Pospelova and JP Julien
Institute of Cytology, Russian Academy of Sciences, St. Petersburg.

Changes in the neuronal content of neurofilament proteins occur in some neuropathological conditions, but little is known about the molecular mechanisms that control both the cell type specificity and the levels of expression of neurofilament genes. In addition to TATA and Sp1 elements, we report here the presence in the neurofilament light (NF-L) promoter region of other regulatory elements, namely, an AP-1 element TGCGTCAG, a Krox-24 element GCACCCCGC, and an Ets-like element AGCAAGCAGGAATTT. These elements constitute binding sites for specific nuclear factors present in aggregated P19 embryonal carcinoma cells. Using cotransfection assays in P19 embryonal carcinoma cells, we show that NF-L promoter fragments fused to the reporter chloramphenicol acetyltransferase gene can be trans-activated by expression vectors encoding FOS and JUN (AP-1) and by Krox-24 protein. The finding of functional elements for immediate early gene products in the NF-L promoter suggests molecular pathways by which the modulation of neurofilament expression can be coupled to growth factors and other external stimuli.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. V. Abramova, T. V. Pospelova, F. P. Nikulenkov, C. M. Hollander, A. J. Fornace Jr., and V. A. Pospelov
G1/S Arrest Induced by Histone Deacetylase Inhibitor Sodium Butyrate in E1A + Ras-transformed Cells Is Mediated through Down-regulation of E2F Activity and Stabilization of beta-Catenin
J. Biol. Chem., July 28, 2006; 281(30): 21040 - 21051.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
C. McCoy, S. B. McGee, and M. M. Cornwell
The Wilms' Tumor Suppressor, WT1, Inhibits 12-O-Tetradecanoylphorbol-13-acetate Activation of the Multidrug Resistance-1 Promoter
Cell Growth Differ., June 1, 1999; 10(6): 377 - 386.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. J. Yaworsky, D. P. Gardner, and C. Kappen
Transgenic Analyses Reveal Developmentally Regulated Neuron- and Muscle-specific Elements in the Murine Neurofilament Light Chain Gene Promoter
J. Biol. Chem., October 3, 1997; 272(40): 25112 - 25120.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Stripling, S. F. Volman, and D. F. Clayton
Response Modulation in the Zebra Finch Neostriatum: Relationship to Nuclear Gene Regulation
J. Neurosci., May 15, 1997; 17(10): 3883 - 3893.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.